Abstract
Post-menopausal women who have never used hormone replacement therapy have a higher risk of colon, but not rectal, cancer than do premenopausal women of the same age, socio-cultural class and dietary habits. Such risk increase seems to last about 10 years and to be restricted to lean women, a group who have lower levels of oestradiol after ovarian function ceases after menopause. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Breslow NE and Day NE (1980) Statistical Methods in Cancer. The Analysis of Case–control Studies. I, IARC Scientific Publication No 32, International Agency for Research on Cancer: Lyon
Burger HG, Dudley EC, Hpper JL, Shelley JM, Green A, Smith A, Dennerstein L and Morse C (1995) The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab 80: 3537–3545
Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative re-analysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 350: 1047–1059
Di Domenico M, Castoria G, Bilancio A, Migliaccio A and Auricchio F (1996) Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res 56: 4516–4521
English MA, Kane KF, Cruickshank N, Langman MJS, Stewart PM and Hewison M (1999) Loss of estrogen inactivation in colonic cancer. J Clin Endocrinol Metab 84: 2080–2085
Fernandez E, La Vecchia C, Braga C, Talamini R, Negri E, Parazzini F and Franceschi S (1998) Hormone replacement therapy and risk of colon and rectal cancer. Cancer Epidemiol Biomarkers Prev 7: 329–333
Franceschi S and La Vecchia C (1998) Colorectal cancer and hormone replacement therapy: an unexpected finding. Eur J Cancer Prev 7: 427–438
Franceschi S, Bidoli E, Talamini R, Barra S and La Vecchia C (1991) Colorectal cancer in Northeast Italy: reproductive, menstrual and female hormone-related factors. Eur J Cancer 27: 604–608
Hahnn RA, Eaker E and Rolka H (1997) Reliability of reported age at menopause. Am J Epidemiol 146: 771–775
Hébert-Croteau N (1998) A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biormarkers Prev 7: 653–659
IARC (1999). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Some Hormones, Postmenopausal Hormone Therapy, and Hormonal Contraception 72, International Agency for Research on Cancer: Lyon
Jacobs EJ, White E and Weiss NS (1994) Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes Control 5: 359–366
Kampman E, Bijl AJ, Kok C and van’t Veer P (1994) Reproductive and hormonal factors in male and female colon cancer. Eur J Cancer Prev 3: 329–336
Kampman E, Potter JD, Slattery ML, Caan BJ and Edwards S (1997) Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case–control study in the United States. Cancer Causes Control 8: 146–158
Kuiper GGJM and Gustafsson J-A (1997) The novel estrogen receptor β subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS 410: 87–90
La Vecchia C and Franceschi S (1991) Reproductive factors and colorectal cancer. Cancer Causes Control 2: 193–200
Martinez ME, Grodstein F, Giovannucci E, Colditz GA, Speizer FE, Hennekens C, Rosner B, Willett WC and Stampfer MJ (1997) A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 6: 1–5
Negri E, La Vecchia C, Parazzini F, Savoldelli R, Gentile A, D’Avanzo B, Gramenzi A and Franceschi S (1989) Reproductive and menstrual factors and risk of colorectal cancer. Cancer Res 49: 7158–7161
Negri E, Tzonou A, Beral V, Lagiou P, Trichopoulos D, Parazzini F, Franceschi S, Booth M and La Vecchia C (1999) Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies. Int J Camcer 80: 848–851
Parkin DM, Whelan SL, Ferlay J, Raymond L and Young J (1997) Cancer Incidence in Five Continents. VII, IARC Scientific Publication No 143.p, International Agency for Research on Cancer: Lyon
Rannevik G, Jeppsson S, Johnell O, Bjerre B, Lurell-Borulf Y and Svanberg L (1995) A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 21: 103–113
Talamini R, Franceschi S, Dal Maso L, Negri E, Conti E, Filiberti R, Montella M, Nanni O and La Vecchia C (1998) The influence of reproductive and hormonal factors on the risk of colon and rectal cancer in women. Eur J Cancer 34: 1070–1076
Troisi R, Schairer C, Chow W-H, Schatzkin A, Brinton LA and Fraumeni JF Jr (1997) Reproductive factors, oral contraceptive use, and risk of colorectal cancer. Epidemiology 8: 75–79
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Franceschi, S., Gallus, S., Talamini, R. et al. Menopause and colorectal cancer. Br J Cancer 82, 1860–1862 (2000). https://doi.org/10.1054/bjoc.1999.1084
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1084
Keywords
This article is cited by
-
Survival and long-term surgical outcomes after colorectal surgery: are there any gender-related differences?
Updates in Surgery (2022)
-
Gender comparison of clinical, histopathological, therapeutic and outcome factors in 185,967 colon cancer patients
Langenbeck's Archives of Surgery (2020)
-
A novel role for estrogen-induced signaling in the colorectal cancer gender bias
Irish Journal of Medical Science (1971 -) (2019)
-
Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population
BMC Cancer (2014)
-
Gender and oncology: Pathological observations
memo - Magazine of European Medical Oncology (2011)